Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole


Viale G., Giobbie-Hurder A., Regan M. M., Coates A. S., Mastropasqua M. G., Dell'Orto P., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.26, sa.34, ss.5569-5575, 2008 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 34
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1200/jco.2008.17.0829
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.5569-5575
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Purpose To evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial comparing letrozole (Let) with tamoxifen (Tam) as adjuvant therapy in postmenopausal women with early breast cancer.